ArticleCurrent research in food science2026
Multimodal molecular features enable interpretable umami peptide screening and structure-activity analysis.
Article in Current research in food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Umami peptides are important taste-active components in protein-rich foods, but their computational discovery is still constrained by predictors that rely mainly on sequence information and provide limited mechanistic interpretability. In this study, BioPP-GFD was developed as an interpretable multimodal deep learning framework for umami peptide screening and structure-activity analysis. The model integrates molecular graphs, molecular fingerprints, and physicochemical descriptors through adaptive channel attention. In the umami-bitter peptide classification task, BioPP-GFD achieved an accuracy of 0.932 ± 0.028, sensitivity of 0.919 ± 0.023, specificity of 0.944 ± 0.041, and Matthews correlation coefficient of 0.864 ± 0.056, outperforming Umami-Transformer and UniDL4BioPep in most overall metrics. Supplementary evaluation across additional bioactivity-specific peptide datasets further indicated the cross-task applicability of the multimodal architecture to other peptide classification tasks. Interpretability analysis showed that the fingerprint and descriptor branches contributed strongly to the discrimination of umami peptides from bitter peptides. Directional occlusion and fingerprint evidence mapping distinguished umami-supporting substructures from bitter-associated cues. Atom-pair attention analysis of strongly active umami peptides, with activity thresholds ranging from 0.003 to 0.1998 mM, localized prediction-relevant regions to carboxylate-bearing termini, amide-linked segments, and other heteroatom-rich environments. Molecular docking with the T1R1 and T1R3 receptor model further supported the receptor-level relevance of these hotspots, with docking energies ranging from -6.846 to -8.325 kcal/mol and recurrent hydrogen-bonding, electrostatic, and hydrophobic contacts. These findings suggest that BioPP-GFD provides an interpretable strategy for umami peptide screening and receptor-level structure-activity analysis, supporting the rational discovery of taste-active functional food peptides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.